Sep 11, 2026Manufacturing & Quality

Skincare Manufacturing Quality Agreement: What Brands and Manufacturers Should Define

Build a practical skincare manufacturing quality agreement covering responsibilities, specifications, changes, release, records, complaints and communication.

BIO-TIDE laboratory team walking through a controlled research facility

A manufacturing contract tells a skincare brand what it will buy. A quality agreement tells both parties who controls the decisions that can change product quality. The most useful version is not the longest one; it is the one a project team can use during a deviation, change or complaint without guessing who owns the next step.

This article is a commercial-quality planning guide, not legal advice. Responsibilities should be adapted to the product, target market, operating model and advice of qualified quality, regulatory and legal professionals.

Begin with a responsibility matrix

Before drafting paragraphs, build a one-page matrix. For every critical activity, name who performs it, who approves it, who must be consulted and who must be informed.

The matrix should cover at least:

formula and finished-product specification control;

raw material and packaging approval;

manufacturing instruction and scale-up approval;

sampling, testing and result review;

deviation and out-of-specification assessment;

batch disposition and shipment release;

artwork and market information supplied by the brand;

complaint, return and market-action support.

“Brand quality” and “manufacturer quality” are not enough if individual decisions remain unclear. Use named roles or controlled contact points, including an urgent escalation route.

Seven clauses that prevent the most common gaps

1. Product and document scope

Identify the products, production sites and markets covered by the agreement. List the controlled documents that define the approved product: master formula, manufacturing instruction, finished-product specification, packaging specification, approved artwork and agreed test plan. Each document needs a version or date.

If the acceptance criteria are still incomplete, resolve them before treating the agreement as finished. A quality agreement should point to the governing documents, not hide missing product decisions.

2. Change control

Define which changes require notice, technical review or written approval before implementation. Examples include a supplier, raw material grade, process parameter, production site, test method, packaging component, decoration or artwork change.

The notice should explain what changed, why it changed, which products are affected and what evidence supports the decision. A fixed number of notice days is not enough without an impact review.

3. Deviations and investigations

State which events the manufacturer can resolve within its system and which events require customer notification or approval before release. A useful deviation record identifies the event, affected batch or material, evidence reviewed, risk decision, correction and follow-up.

The agreement should also address recurring events. Closing one deviation is different from deciding whether a pattern needs corrective action or a change to the process.

4. Batch release and shipment

Separate manufacturing completion, quality disposition and commercial shipment. Define who reviews the batch, which acceptance criteria apply, what document package is supplied and whether any customer approval is required before stock leaves the site.

Connect this section to the cosmetic batch release checklist and the correct batch traceability plan. The agreement should not link to a generic or obsolete record path.

5. Complaints, returns and market support

Define where complaints enter, which minimum information is collected, how serious signals are escalated, when retained samples or batch records are reviewed and who communicates the investigation outcome.

A consumer comment is not automatically a manufacturing defect. Start with structured evidence: product and batch identity, market, purchase channel, use history, photographs where relevant and the condition of any returned unit.

6. Records, access and confidentiality

List which documents are supplied routinely, which remain at the manufacturing site and how they can be requested for an audit, complaint or regulatory question. Define retention, response expectations and protection of confidential formula or supplier information.

This gives the brand access to relevant evidence without requiring the manufacturer to hand over its entire quality system.

7. Review and termination

State when the agreement and contact list are reviewed. Also define how open deviations, records, retained samples, complaints and product transfers are handled if the commercial relationship ends. A quality responsibility should not disappear because ordering has stopped.

The document package to agree per batch

The right package depends on risk and market, but it should be explicit. It may include:

batch identity and manufacturing date;

release or conformity statement;

agreed finished-product results;

packaging and coding confirmation;

unresolved deviation status, where applicable;

shipment authorization or customer approval record.

Do not request documents merely to build a larger folder. Each item should support a defined decision or future investigation.

Four warning signs

The same party performs and approves every critical decision without a defined review.

“Any change” requires approval, but the agreement never defines what information accompanies a change.

The brand expects to approve release while the manufacturer expects shipment to proceed automatically.

Complaint and record-access duties are described only after a problem occurs.

These gaps are easier to resolve before the first purchase order than during a delayed shipment.

Regulatory context

ISO 22716:2007 provides current ISO guidance for cosmetic production, control, storage and shipment. In the EU, Regulation (EC) No 1223/2009 requires manufacture to comply with good manufacturing practice and requires the Product Information File to contain a description of the manufacturing method and a statement of GMP compliance. These sources establish responsibilities around compliant manufacture; they do not supply a universal brand–manufacturer contract.

Use the agreement as an operating tool

Test the draft with three scenarios: a packaging supplier changes a component, a batch has an unusual result, and a consumer complaint arrives six months after shipment. If the team can identify the owner, evidence, approval path and communication deadline for each scenario, the agreement is becoming usable.

BIO-TIDE can help align formulation, sampling, packaging and production responsibilities within a defined development scope. Discuss your manufacturing plan before responsibilities are locked into separate contracts and email threads.

Frequently Asked Questions

How is a quality agreement different from the manufacturing contract?

The manufacturing contract tells a skincare brand what it will buy. A quality agreement tells both parties who controls the decisions that can change product quality. The most useful version is not the longest one; it is the one a project team can use during a deviation, change or complaint without guessing who owns the next step.

Which activities should the responsibility matrix cover?

At minimum: formula and finished-product specification control; raw material and packaging approval; manufacturing instruction and scale-up approval; sampling, testing and result review; deviation and out-of-specification assessment; batch disposition and shipment release; artwork and market information supplied by the brand; and complaint, return and market-action support. Use named roles or controlled contact points, including an urgent escalation route.

What belongs under change control in a quality agreement?

Changes that require notice, technical review or written approval before implementation include a supplier, raw material grade, process parameter, production site, test method, packaging component, decoration or artwork change. The notice should explain what changed, why, which products are affected and what evidence supports the decision; a fixed number of notice days is not enough without an impact review.